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Purpose or Objective 
In prostate image guided radiotherapy (IGRT), a recent 
randomized trial reported an occurrence of other 
malignancies two times higher in case of a daily imaging 
control compared to a weekly control (de Crevoisier, 
IJROBP 2018). The purpose of this study was to measure 
the additional out of field dose delivered by various 
imaging modalities. 
Material and Methods 
An anthropomorphic phantom was used to mimic a total 
dose of 78 Gy delivered in the prostate by IMRT/IGRT. We 
measured the dose related to three imaging techniques (a 
pair of orthogonal portal images (PI) (6 MV, 2 UM/image), 
a pair of orthogonal kV images (75 kV, 10 mAs and 105 kV, 
80 mAs) and a standard full kV-CBCT (125 kV, 676 mAs)). 
The doses were measured for 21 points along the central 
axis of the phantom with thermoluminescent dosimeters 
(GR-200A). These doses were compared to the measured 
doses related to the treatment (IMRT, 5 beams, 6 MV, 
sliding window technique). Finally, the doses for various 
kV-CBCT parameters were computed: a low dose (260 
mAs) and a high dose protocol (1300 mAs). 
Results 
Figure 1 shows the measured out of field dose for the three 
imaging modalities for one fraction/control. Orthogonal 
kV imaging (2D-kV) provides the minimum dose inside 
(1.12 mGy at 0 cm) and outside the field (0.11 mGy at 20 
cm, corresponding to 10 cm from the imaging field edge). 
Standard kV-CBCT imaging provides less dose inside the 
field (18.6 mGy at 0 cm) than PI (28.8 mGy at 0 cm) but 
more dose outside the field (1.36 mGy at 20 cm) compared 
to PI (0.87 mGy at 20 cm). The high dose kV-CBCT protocol 
provides the maximum out of field dose (2.62 mGy at 20 
cm), while using a low dose kV-CBCT protocol provides less 
dose (0.52 mGy at 20 cm) than PI. The out of field doses 
related to IMRT are superior to all the imaging control 
modalities (8.65 mGy at 20 cm). 
Considering a weekly control by 2D-kV imaging (8 controls) 
and a daily control by a standard kV-CBCT imaging 
(39 controls), the doses at 20 cm were 0.90 mGy and 53.1 
mGy, respectively. However, when considering a daily 
control by 2D-kV imaging and a weekly control by a low 
dose kV-CBCT imaging the doses are similar with 4.3 mGy 
at 20 cm.  
Figure 1: Measured dose profiles for one fraction of IMRT 
(SW: sliding window technique), one pair of orthogonal 
portal images (6 MV, 2 MU/image), one pair of orthogonal 
kV images (75 kV 10 mAs, 105 kV 80 mAs) and one full kV-
CBCT (125 kV) with either 260 mAs (low dose), 676 mAs 
(standard) and 1300 mAs (high dose). The origin represents 
the treatment and imaging isocenters and is located at the 
prostate barycenter. 
Conclusion 
Both imaging modality and control frequency as well as 
treatment fields have an impact on the out of field dose. 
Regarding one imaging control session, the out of field 
dose ranges from 0.1 to 2.6 mGy at 10 cm from the 
imaging field edge. 
